Medical Affairs

Medical Affairs

Medical Affairs contributes to defining the optimal role of our medicines in the treatment of various conditions and diseases. Our Medical Affairs specialists possess a deep understanding of disease presentation, treatment paradigms and the potential role of our medicines in patient care. Activities include assesing and defining clinical and scientific evidence needs, designing clinical studies to generate relevant data and exploring potential new indications for currently approved drugs. Patient value is enhanced when access to Mallinckrodt products is increased through a clear communication of the value of our products to meet the needs of our patients.

Publications

We are dedicated to timely and effective scientific communication of our research efforts. The files below provide details on these efforts.

Click here for a bibliography of publications for H.P. Acthar® Gel (repository corticotropin injection).

Click here for a bibliography of publications for INOMAX® (nitric oxide) gas for inhalation.

Click here for a bibliography of publications for OFIRMEV® (acetaminophen) injection.